HomeCompareGLWLF vs MO

GLWLF vs MO: Dividend Comparison 2026

GLWLF yields 4878.05% · MO yields 9.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GLWLF wins by $48953635367862.17M in total portfolio value
10 years
GLWLF
GLWLF
● Live price
4878.05%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48953635367862.20M
Annual income
$47,056,025,708,614,450,000.00
Full GLWLF calculator →
MO
Altria Group Inc.
● Live price
9.11%
Share price
$44.80
Annual div
$4.08
5Y div CAGR
4.3%
Payout ratio
78%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.7K
Annual income
$4,052.72
Full MO calculator →

Portfolio growth — GLWLF vs MO

📍 GLWLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLWLFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLWLF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLWLF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLWLF
Annual income on $10K today (after 15% tax)
$414,634.15/yr
After 10yr DRIP, annual income (after tax)
$39,997,621,852,322,280,000.00/yr
MO
Annual income on $10K today (after 15% tax)
$774.11/yr
After 10yr DRIP, annual income (after tax)
$3,444.81/yr
At 15% tax rate, GLWLF beats the other by $39,997,621,852,322,280,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLWLF + MO for your $10,000?

GLWLF: 50%MO: 50%
100% MO50/50100% GLWLF
Portfolio after 10yr
$24476817683931.11M
Annual income
$23,528,012,854,307,226,000.00/yr
Blended yield
96.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

GLWLF
No analyst data
Altman Z
-3.2
Piotroski
3/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
+36.7% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLWLF buys
0
MO buys
0
No recent congressional trades found for GLWLF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLWLFMO
Forward yield4878.05%9.11%
Annual dividend / share$2.00$4.08
Payout ratio50%78%
1-year div growth0%4.1%
5-year div CAGR0%4.3%
Portfolio after 10y$48953635367862.20M$27.7K
Annual income after 10y$47,056,025,708,614,450,000.00$4,052.72
Total dividends collected$48825140738705.46M$20.9K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GLWLF vs MO ($10,000, DRIP)

YearGLWLF PortfolioGLWLF Income/yrMO PortfolioMO Income/yrGap
1← crossover$498,505$487,804.88$10,740$949.88+$487.8KGLWLF
2$23,259,859$22,726,458.99$11,601$1,086.84+$23.25MGLWLF
3$1,015,915,457$991,027,407.41$12,608$1,250.75+$1015.90MGLWLF
4$41,540,182,244$40,453,152,705.37$13,792$1,448.20+$41540.17MGLWLF
5$1,590,340,977,519$1,545,892,982,517.95$15,190$1,687.69+$1590340.96MGLWLF
6$57,013,427,657,541$55,311,762,811,595.47$16,851$1,980.28+$57013427.64MGLWLF
7$1,914,197,254,068,091$1,853,192,886,474,521.50$18,838$2,340.48+$1914197254.05MGLWLF
8$60,197,744,519,759,976$58,149,553,457,907,120.00$21,230$2,787.44+$60197744519.74MGLWLF
9$1,773,466,971,259,579,400$1,709,055,384,623,436,000.00$24,130$3,346.72+$1773466971259.56MGLWLF
10$48,953,635,367,862,200,000$47,056,025,708,614,450,000.00$27,676$4,052.72+$48953635367862.17MGLWLF

GLWLF vs MO: Complete Analysis 2026

GLWLFStock

Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.

Full GLWLF Calculator →

MOConsumer Staples

Altria is a Dividend King with 54+ consecutive years of dividend increases — one of the longest streaks in American corporate history. While cigarette volumes decline, pricing power and new product categories (oral nicotine pouches via NJOY) support cash flows. The near-9% yield is among the highest in the S&P 500.

Full MO Calculator →
📬

Get this GLWLF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLWLF vs SCHDGLWLF vs JEPIGLWLF vs OGLWLF vs KOGLWLF vs MAINGLWLF vs PMGLWLF vs BTIGLWLF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.